A summary of the exhaustive analyses of human insulin (recombinant DNA) shows chemical, structural, and biologic equivalence to pancreatic human insulin. The high degree of purity accounts for its lack of pyrogenicity and immunogenic contamination. Human insulin from both the proinsulin and chain combination methods is essentially identical. The role of proinsulin as an alternate route to human insulin, and as a new treatment for diabetes when used alone or in combination with human insulin or connecting peptide, warrants further investigation.
Skip Nav Destination
Symposium on Human Insulin of Recombinant DNA Origin| November 01 1982
Authenticity and Purity of Human Insulin (recombinant DNA)
Address reprint requests to Irving S. Johnson, Lilly Research Laboratories, 307 East McCarty Street, Indianapolis, Indiana 46285
Irving S Johnson; Authenticity and Purity of Human Insulin (recombinant DNA). Diabetes Care 1 November 1982; 5 (Supplement_2): 4–12. https://doi.org/10.2337/diacare.5.2.S4
Download citation file: